Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial

Surena Vahabi; Bahareh Nazemisalman; Mahsa Kalantari; Sepanta Hosseinpour

doi:10.5812/ircmj.84396

Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial

Surena Vahabi ¹ , Bahareh Nazemisalman ^{2
, *} , Mahsa Kalantari ³ and Sepanta Hosseinpour ⁴

Authors Information

¹ Periodontics Department, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran

² School of Dentistry, Zanjan University of Medical Sciences, Zanjan, Iran

³ Zanjan University of Medical Sciences, Zanjan, Iran

⁴ School of Dentistry, University of Queensland, Brisbane, Australia

Article information

Iranian Red Crescent Medical Journal: January 31, 2019, 21 (1); e84396
Published Online: January 27, 2019
Article Type: Research Article
Received: September 18, 2018
Revised: December 22, 2018
Accepted: December 25, 2018
DOI: 10.5812/ircmj.84396

To Cite: Vahabi S, Nazemisalman B, Kalantari M, Hosseinpour S. Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial, Iran Red Crescent Med J. 2019 ; 21(1):e84396. doi: 10.5812/ircmj.84396.

Abstract

Methods: This analytical case-control study was performed among 141 participants including 63 CP cases and 78 matched healthy individuals. Five milliliters of peripheral blood was collected for DNA isolation. Restriction fragment length polymorphism- polymerase chain reaction (RFLP-PCR) was performed for single-nucleotide polymorphism (SNP) analysis. The frequencies were analyzed by chi-squared test (95% CI, P < 0.05). In addition, genetic data were assessed by the Hardy-Weinberg principle, linkage disequilibrium, and haplotype analysis.

Results: Our findings presented no significant relationship between genotype/alleles of MMP-1 -1607 1G/2G (rs1799750) (0.73: 0.27 - 1.95, P = 0.48) or CRP 717 A/G (rs2794521) (0.384: 0.104 - 1.414, P = 0.303) and the presence of CP (P = 0.47 and P = 0.30, respectively). The analysis of genetic distribution among various severities of CP and controls revealed no significant association between various severities of CP and MMP-1 -1607 1G/2G (rs1799750) (P = 0.52) and CRP 717 A/G (rs2794521) (P = 0.67).

Keywords: Chronic Periodontitis; C-Reactive Protein; Genes; Matrix; Metalloproteinase-1; Polymorphism; Risk Factors

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited

1. Background

Chronic periodontitis (CP) is a complex inflammatory disease, which commonly progresses slowly. This disease is initiated by pathogenic microorganisms, the host's response and environmental factors (1) and is estimated to have a prevalence of 5% to 79.6% (2). As an inflammatory disease, CP could not only destroy periodontium due to host immune response and pathological plaques (2, 3) but also it can cause tooth loss and affect systemic health (4-10).

Periodontal tissues in CP are characterized by the accumulation of Gram-negative bacteria and inflammatory cells (11). It has been proposed that the balance in the secretion of cytokines from type 1 T-helper cells and type 2 T-helper cells in host immune response is an important factor for the determination of inflammatory diseases' consequences (12). In fact, a complex network between cytokines regulates the inflammatory and immune responses in periodontal tissues during a periodontal disease (13).

It has been suggested that the imbalance in the secretion of matrix metalloproteinases (MMPs) and tissue inhibitor metalloproteinase initiates the destructive process in CP (14). These cytokines normally regulate fibrosis formation, and extracellular matrix (ECM) turn over (13). Moreover, the elevated expression of MMPs has been observed in several inflammatory diseases like atherosclerosis (15), osteoarthritis (16) and ovarian cancer (17). Within MMPs family, MMP-1 is the most common element of the periodontal tissue matrix (18, 19), which adjusts the biodegradation of interstitial collagen fibers (20). Overexpression of MMP-1 in periodontal tissues has been reported in periodontitis (21), and it seems MMP-1 is locally secreted in periodontitis by stimulated fibroblasts (22).

Genetic diversity in MMP genes can affect its expression level (23), and ECM degradation can lead to the development of periodontitis (24-26). The MMP-1 gene has a single nucleotide polymorphic (SNP) region at -1607 base pair (27, 28), and previous studies have shown the association of its 2G/2G genotype with CP in different populations (27, 28).

During the past decades, the association between periodontal diseases and systemic health has been reported due to local bacterial mediators or systemic host immune mediators (29). C-reactive protein (CRP) is a systemic inflammatory mediator that reflects an acute immune response (30). CRP is produced and released by the liver due to fever, infection and hypoxia, and is one of the most sensitive markers used to assess the inflammatory status (31, 32). There is an association between increased level of CRP in the peripheral blood and periodontal ligament, and this relationship seems to be dose-dependent (CRP level ranging from 1 to 4 mg/L indicates healthy periodontal condition to severe periodontitis) (33). In addition, previous studies demonstrated a reduction in plasma levels of CRP after periodontal treatments and decreased inflammation (34). Different studies among diverse populations showed a variation in increased levels of CRP within patient and control groups (34, 35), which suggests the impact of other factors including genetic variations in host responses in periodontitis. Only a few studies have studied CRP gene polymorphisms in CP, which reported an association between CRP 717 heterogeneous type within patients and normal subjects (36).

2. Objectives

3. Methods

3.1. Sample Preparation and Examinations

In the present case-control investigation that was performed during 2016 - 2017 in Zanjan, Iran, 170 individuals were examined. All the procedures were approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences and the ethical guidelines of the Helsinki Declaration. The inclusion criteria for both groups (patients and matched healthy individuals) were being over 21 years old, being Iranian, having more than 20 teeth, and not having any systemic health problems (except chronic periodontitis). The exclusion criteria, on the other hand, were the presence of systemic health problems such as diabetes, HIV infection, hepatitis and various malignancies. Moreover, we excluded pregnant patients or those who were taking antibiotics in the past three months. After obtaining written informed consent, the individuals were assessed by an experienced periodontist using a standard Williams probe (grading 1 - 2 - 3 - 5 - 7 - 8 - 9 - 10 mm).

After that, chronic periodontitis cases were determined and divided into mild, moderate and severe groups according to the American Academy of Periodontology (AAP) classification guideline (37). The control group consisted of gingivitis cases and healthy individuals. For each patient, probing depth (PD), bleeding on probing (BOP), and clinical attachment loss (CAL) were determined at six sites (i.e., mesiobuccal, buccal, distobuccal, distolingual, lingual and mesiolingual) of each tooth. Finally, the mean PD, BOP and CAL of each individual was calculated. In this study, CP cases who had 30% > affected teeth with ≥ 5 mm CAL, 3 - 4 mm CAL and 1 - 2 mm CAL were considered as severe, moderate and mild CP, respectively.

3.2. DNA Extraction and Genotyping

We obtained 5 mL of peripheral blood samples with standard venipuncture and collected the samples in tubes containing EDTA (Sarstedt, Numbrecht, Germany). DNA was extracted by a DNA extraction kit (CinnaGen Inc., Tehran, Iran) and modified salting-out method previously used by Miller et al. (37). Restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) was applied to determine genotypes and single-nucleotide polymorphisms. At first, 50 ng of DNA produced by PCR was exposed to restriction enzymes (TaqI, SacII and Bsp restrictive enzymes [New England Bio Labs, Beverly, MA, USA]) and purged by silica gel membrane (QIAquick PCR Puriﬁcation Kit, Quiagen, Hilden, Germany). The analysis of the single-nucleotide polymorphisms of MMP-1 -1607 1G/2G (rs1799750) and CRP 717 C/T (rs2794521) were performed (Table 1). For the PCR reactions, at first the specimens were denaturized at 95°C for 15 minutes, followed by 35 cycles at 94°C for 30 seconds, 58°C for 30 seconds, 72°C for 30 seconds, and 72°C for 10 minutes. Then, all the remaining sequences were analyzed by electrophoresis on 2% agarose gel stained by Gel Red (Biotium Inc., Hayward, CA, USA).

Table 1. Primers and Nucleotide Polymorphisms for CRP and MMP-1 Which Were Utilized in This Study

Gene (Genebank code)	Primer Sequence	Size (bp)	Restriction Enzyme (bp)	Annealing Temperature (°C)
CRP -717C/T (rs2794521)	5’- TCAATTGGCTGAGAAAATGTGTC-3’	502	BstUI (Bsh1236I); 44 + 458	60
CRP -717C/T (rs2794521)	5’- AATGGGAAATGGTAACATATTAAC-3’	502	BstUI (Bsh1236I); 44 + 458	60
MMP1 -1607 1G/2G (rs1799750)	5’-TCGTGAGAATGTCTTCCCATT-3’	118	AluI; 28 + 90 (1G)	58
MMP1 -1607 1G/2G (rs1799750)	5’-TCTTGGATTGATTTGAGATAAGTCATAgC-3’	118	AluI; 28 + 90 (1G)	58

Abbreviations: CRP, C-reactive protein; MMP1, matrix metalloproteinase 1; SNPs, single nucleotide polymorphisms.

3.3. Statistical Analysis

PD, BOP and CAL were analyzed descriptively and the distribution of the means was compared between the groups. For testing normality of the data, Kolmogorov-Smirnov test was performed and paired and unpaired t tests were run to compare the groups (CP and control). In addition, the chi-squared test was used for phenotypic analysis. The statistical procedures were performed by SPSS version 20.0 at the significance level of 5% with 95% confidence interval. Haploview 4.2 software (Cambridge, Massachusetts, USA) was used to evaluate the deviation from Hardy-Weinberg principle, multiple inheritance models, and linkage disequilibrium and haplotype conditions.

4. Results

4.1. Demographic and Clinical Data

Twenty-nine individuals were excluded due to incomplete cooperation, and 141 participants (77 healthy individuals and 64 CP patients) were enrolled. Table 2 displays the demographic and clinical data. The comparison of demographic and periodontal status between the groups showed a non-significant difference between the groups in terms of gender and age (P = 0.31 and P = 0.09, respectively), but PD and CAL were significantly higher in the patient group (P = 0.001).

Table 2. Demographic Data and Periodontal Parameters of the Subjects Recruited to This Study^a

Variable	Study Groups		P Value
Variable	Control (N = 78)	Chronic Periodontitis (N = 63)	P Value
Age, y	34.22 ± 11.07	37.61 ± 12.63	0.091^b
Gender, No. (%)			0.317^c
Male	27 (34.6)	27 (42.8)
Female	51 (65.3)	36 (57.1)
PD, mm	1.59 ± 0.21	2.9 ± 1.34	0.001^b
CAL, mm	0.21 ± 0.31	2.8 ± 1.53	0.001^b
BoP, %	9.83 ± 15.32	16.48 ± 17.71	0.040^b
Frequency of periodontitis, No. (%)			-
Mild	-	20 (31.7)
Moderate	-	24 (38)
Severe	-	20 (31.7)

^a Values are expressed as mean ± SD unless otherwise indicated.

^bt test.

^b Pearson chi-square.

4.2. Genetic Data

All the genotypes and allelic distribution within the groups are presented in Table 3. We found no significant association between genotype/phenotype of MMP-1 -1607 1G/2G (rs1799750) and the presence of CP (P = 0.479). Moreover, no statistically significant association was observed between chronic periodontitis and CRP -717 C/T gene polymorphism (rs731236) (P = 0.303). The comparison of genetic distributions (genotypes and alleles) among various severities of CP and healthy individuals (Table 4) revealed a significant relationship among various severities of CP and MMP-1 -1607 1G/2G (P = 0.52) or CRP -717 C/T gene polymorphism (P = 0.67). None of the investigated SNPs met the Hardy Weinberg principle (38).

Table 3. Distribution of Genotypes and Alleles for Matrix Metalloproteinase-1 (MMP-1) -1607 1G/2G and C-Reactive Protein (CRP) -717 C/T Gene Polymorphisms Among Controls and Chronic Periodontitis Group

Genotypes and Alleles	Controls	CP Cases	OR (95% CI)	P Value
CRP
T/T	6	10	1	0.303
T/C	43	32	0.382 (0.111 - 1.313)
C/C	27	19	0.384 (0.104 - 1.414)
T	52	55	1	0.319
C	70	97	1.310 (0.8041 - 2.135)	0.319
Hardy-Weinberg equilibrium	0.049	0.571
MMP1
2G/2G	19	14	1	0.479
1G/2G	29	19	0.730 (0.273 - 1.954)
1G/1G	29	30	1.292 (0.505 - 3.303)
1G	87	79	1	0.328
2G	67	47	1.294 (0.7997 - 2.095)	0.328
Hardy-Weinberg equilibrium	0.040	0.004

Table 4. Distribution of the Matrix Metalloproteinase-1 (MMP-1) -1607 1G/2G and C-Reactive Protein (CRP) -717 C/T Genotypes in the Study Groups Based on the Periodontitis Severity

Genotype	Controls		CP Cases			OR (95% CI)	P Value
Genotype	Healthy	Gingivitis	Mild CP	Moderate CP	Severe CP	OR (95% CI)	P Value
MMP1							0.521
2G/2G	15	4	2	6	6	REF
2G/1G	19	9	6	6	8	0.774 (0.303 - 197)
1G/1G	23	19	20	24	20	0.565 (0.238 - 1.34)
CRP							0.67
TT	4	1	4	3	4	REF
TC	31	12	8	14	10	2.605 (0.707 - 90.59)
CC	21	6	6	7	6	0.994 (0.437 - 2.25)

5. Discussion

Previous studies have shown that genetic factors may increase the risk of periodontitis, one of the most prevalent inflammatory conditions, through potential interactions that are not still completely described (39). In the current study, we aimed to assess the relationship between the MMP-1 -1607 1G/2G (rs1799750) and CRP 717 A/G (rs2794521) single-nucleotide gene polymorphisms and CP in Iranian patients for the first time. Our findings showed no significant relationship between genotype/phenotype of MMP-1 -1607 1G/2G (rs1799750) or CRP 717 A/G (rs2794521) and the occurrence or severity of CP.

Li et al. in 2016 conducted a review to evaluate the role of various MMPs in the risk of periodontal diseases (40). In accordance with our results, they could not find any significant relationship between MMP-1 -1607 1G/2G SNP and the risk of periodontal disease in several studies that assessed this association among CP patients. In addition, they failed to associate MMP-1 -519 A/G and -422 A/T SNPs with susceptibility to periodontitis. A possible reason for this finding is that the presence of high diversity in the expression of MMP-1 among periodontitis patients could be due to the additional impact of specific pathogens and cytokine stimulation (41). Moreover, it has been shown that the combination of several significant gene variants can synergistically influence susceptibility to the disease (42). In addition, an increase in mRNA transcription caused by these MMP-1 promoter SNPs may not necessarily intensify the impact of MMP-1 on the surrounding periodontal tissues, and many other factors such as bacterial metabolites, cytokines, and other gene variants are supposed to be involved in the regulation of MMP-1 expression and functionality.

CRPs are commonly produced in immediate inflammatory conditions, infections, and trauma in reaction to other proinflammatory cytokines (43). D’Aiuto et al. reported that CRP gene polymorphism was an independent predictor of CRP expression in intensive periodontal treatment (44). They showed specific genotypes could elevate the serum level of CRP up to its intermediate level at 30 mg/L after periodontal instrumentation. Furthermore, contrary to our results, Auerkari et al. found a relationship between CRP (717) SNP and the risk of periodontal disease in the Indonesian population (36). However, they did not find any significant relationship between CRP (1444) single-nucleotide polymorphism and CP. These discrepancies may be due to different ethnicities or our study’s limited sample size which could have influenced our results. Larger sample size and using sequencing methods may help address these issues.

In conclusion, our results suggested no association between the occurrence or severity of CP and MMP-1 -1607 1G/2G (rs1799750) and CRP 717 A/G (rs2794521) polymorphisms. According to our literature review, this study was the first investigation of the association between gene polymorphisms of CRP and MMP-1 and the risk of periodontal disease among the Iranian population.

Footnotes

Authors' Contribution: Surena Vahabi designed the study, worked on it and supervised. Bahareh Nazemisalman did the literature review and work on it. Mahsa Kalantari and Sepanta Hosseinpour coordinated the study and collected the data.

Conflict of Interests: The authors have no conflicts of interests.

Ethical Considerations: This study was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran, and all the procedures were performed under the supervision of the committee and according to the 1964 Helsinki Declaration.

Funding/Support: We wish to appreciate the Deputy of Research of Shahid Beheshti University of Medical Sciences, Tehran, Iran for the financial support of the article.

Patient Consent: Written informed consent was obtained from all the participants (cases and controls).

References

1. Laine ML, Loos BG, Crielaard W. Gene polymorphisms in chronic periodontitis. Int J Dent. 2010;2010:324719. doi: 10.1155/2010/324719. [PubMed: 20339487]. [PubMed Central: PMC2844543].
2. Dye BA. Global periodontal disease epidemiology. Periodontol 2000. 2012;58(1):10-25. doi: 10.1111/j.1600-0757.2011.00413.x. [PubMed: 22133364].
3. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004;34:9-21. [PubMed: 14717852].
4. Wang J, Qi J, Zhao H, He S, Zhang Y, Wei S, et al. Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep. 2013;3:1843. doi: 10.1038/srep01843. [PubMed: 23673380]. [PubMed Central: PMC3654486].
5. Bergstrom J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol. 1989;17(5):245-7. [PubMed: 2791514].
6. Genco RJ, Ho AW, Grossi SG, Dunford RG, Tedesco LA. Relationship of stress, distress and inadequate coping behaviors to periodontal disease. J Periodontol. 1999;70(7):711-23. doi: 10.1902/jop.1999.70.1.100. [PubMed: 10440631].
7. Chen X, Huang J, Zhong L, Ding C. Quantitative assessment of the associations between interleukin-8 polymorphisms and periodontitis susceptibility. J Periodontol. 2015;86(2):292-300. doi: 10.1902/jop.2014.140450. [PubMed: 25299389].
8. Ding C, Zhao L, Sun Y, Li L, Xu Y. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: A meta-analysis. Arch Oral Biol. 2012;57(6):585-93. doi: 10.1016/j.archoralbio.2012.01.016. [PubMed: 22370044].
9. Mao S, Zhang J, Zhao M, Zhang Y. Association of transforming growth factor-beta1 polymorphisms with the risk of diabetes mellitus. Int J Clin Exp Med. 2015;8(11):21886-92. [PubMed: 26885158]. [PubMed Central: PMC4724004].
10. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306-21. doi: 10.1080/07853890600800103. [PubMed: 16938801].
11. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000. 1997;14:216-48. [PubMed: 9567973].
12. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003;38(2):210-7. [PubMed: 12608917].
13. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248-66. [PubMed: 9715365].
14. Taubman MA, Valverde P, Han X, Kawai T. Immune response: The key to bone resorption in periodontal disease. J Periodontol. 2005;76 Suppl 11S:2033-41. doi: 10.1902/jop.2005.76.11-S.2033. [PubMed: 29539039].
15. Romero JR, Vasan RS, Beiser AS, Polak JF, Benjamin EJ, Wolf PA, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: The Framingham offspring study. J Stroke Cerebrovasc Dis. 2008;17(6):412-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.06.002. [PubMed: 18984437]. [PubMed Central: PMC2613480].
16. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38(3):151-6. doi: 10.1016/j.cyto.2007.06.001. [PubMed: 17689092].
17. Adley BP, Gleason KJ, Yang XJ, Stack MS. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol. 2009;112(2):319-24. doi: 10.1016/j.ygyno.2008.09.025. [PubMed: 18976802]. [PubMed Central: PMC2663392].
18. Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): Their biological functions and involvement in oral disease. J Dent Res. 2006;85(12):1074-84. doi: 10.1177/154405910608501202. [PubMed: 17122157].
19. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand. 2007;65(1):1-13. doi: 10.1080/00016350600963640. [PubMed: 17354089].
20. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol. 2003;74(2):188-95. doi: 10.1902/jop.2003.74.2.188. [PubMed: 12666707].
21. Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol. 1996;41(3):253-62. [PubMed: 8735011].
22. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res. 1994;102(6):342-9. [PubMed: 7871357].
23. Cao Z, Li C, Jin L, Corbet EF. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population. J Periodontal Res. 2005;40(6):427-31. doi: 10.1111/j.1600-0765.2005.00806.x. [PubMed: 16302919].
24. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000;6(4):391-407. [PubMed: 10998429].
25. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491-4. [PubMed: 10419448].
26. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 1993;4(2):197-250. doi: 10.1177/10454411930040020401. [PubMed: 8435466].
27. Holla LI, Jurajda M, Fassmann A, Dvorakova N, Znojil V, Vacha J. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population. J Clin Periodontol. 2004;31(8):685-90. doi: 10.1111/j.1600-051X.2004.00547.x. [PubMed: 15257748].
28. de Souza AP, Trevilatto PC, Scarel-Caminaga RM, Brito RB, Line SR. MMP-1 promoter polymorphism: Association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol. 2003;30(2):154-8. [PubMed: 12622858].
29. Ramamoorthy RD, Nallasamy V, Reddy R, Esther N, Maruthappan Y. A review of C-reactive protein: A diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci. 2012;4(Suppl 2):S422-6. doi: 10.4103/0975-7406.100318. [PubMed: 23066303]. [PubMed Central: PMC3467901].
30. Husain TM, Kim DH. C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J. 2002;15:13-6.
31. Dave S, Batista EL Jr, Van Dyke TE. Cardiovascular disease and periodontal diseases: Commonality and causation. Compend Contin Educ Dent. 2004;25(7 Suppl 1):26-37. [PubMed: 15645884].
32. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996;67(10 Suppl):1123-37. doi: 10.1902/jop.1996.67.10s.1123. [PubMed: 8910831].
33. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76(11 Suppl):2106-15. doi: 10.1902/jop.2005.76.11-S.2106. [PubMed: 16277583].
34. Teeuw WJ, Slot DE, Susanto H, Gerdes VE, Abbas F, D'Aiuto F, et al. Treatment of periodontitis improves the atherosclerotic profile: A systematic review and meta-analysis. J Clin Periodontol. 2014;41(1):70-9. doi: 10.1111/jcpe.12171. [PubMed: 24111886].
35. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277-90. doi: 10.1111/j.1600-051X.2007.01173.x. [PubMed: 18294231].
36. Auerkari E, Suhartono A, Djamal N, Verisqa F, Suryandari D, Kusdhany L, et al. CRP and IL-1B gene polymorphisms and CRP in blood in periodontal disease. Open Dent J. 2013;7:88-93. doi: 10.2174/1874210601307010088. [PubMed: 24009648]. [PubMed Central: PMC3758952].
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. [PubMed: 3344216]. [PubMed Central: PMC334765].
38. Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ. 1986;19(1):1-17. [PubMed: 2425984].
39. Bimstein E, Karimbux N, Needleman HL, Van Dyke TE. Periodontal and gingival health and diseases: Children, adolescents and young adults. CRC Press; 2001.
40. Li W, Zhu Y, Singh P, Ajmera DH, Song J, Ji P. Association of common variants in MMPs with periodontitis risk. Dis Markers. 2016;2016:1545974. doi: 10.1155/2016/1545974. [PubMed: 27194818]. [PubMed Central: PMC4853955].
41. Kasamatsu A, Uzawa K, Shimada K, Shiiba M, Otsuka Y, Seki N, et al. Elevation of galectin-9 as an inflammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo. Int J Biochem Cell Biol. 2005;37(2):397-408. doi: 10.1016/j.biocel.2004.07.014. [PubMed: 15474984].
42. Dowsett SA, Archila L, Foroud T, Koller D, Eckert GJ, Kowolik MJ. The effect of shared genetic and environmental factors on periodontal disease parameters in untreated adult siblings in Guatemala. J Periodontol. 2002;73(10):1160-8. doi: 10.1902/jop.2002.73.10.1160. [PubMed: 12416774].
43. Pizzo G, Guiglia R, Lo Russo L, Campisi G. Dentistry and internal medicine: From the focal infection theory to the periodontal medicine concept. Eur J Intern Med. 2010;21(6):496-502. doi: 10.1016/j.ejim.2010.07.011. [PubMed: 21111933].
44. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005;179(2):413-7. doi: 10.1016/j.atherosclerosis.2004.10.036. [PubMed: 15777561].

Iranian Red Crescent Medical Journal

Published by: Kowsar

Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial

Article information

Abstract

1. Background

2. Objectives

3. Methods

4. Results

5. Discussion

Footnotes

References

Readers' Comments

Iranian Red Crescent Medical Journal

Published by: Kowsar

Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial

Article information

Abstract

1. Background

2. Objectives

3. Methods

4. Results

5. Discussion

Footnotes

References

Share on:

Readers' Comments:

Readers' Comments